Evidence map›Paper›PMID 36844192›Full record

ArticleFuture virology2023

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors.

William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, Lucie Richard, Antoine Lewin, Patrick Trépanier

Abstract read
In one paragraph

Article in Future virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

William LemieuxHéma-Québec, Medical Affairs & Innovation, Québec City & Montréal, Québec, G1V 5G3, Canada.ORCID https://orcid.org/0000-0001-5684-9773
Josée PerreaultHéma-Québec, Medical Affairs & Innovation, Québec City & Montréal, Québec, G1V 5G3, Canada.
Gabriel André Leiva-TorresHéma-Québec, Transfusion Medicine, Québec City & Montréal, Québec, H4R 2W7, Canada.
Nadia BaillargeonHéma-Québec, Transfusion Medicine, Québec City & Montréal, Québec, H4R 2W7, Canada.
Jessica Constanzo YanezHéma-Québec, Transfusion Medicine, Québec City & Montréal, Québec, H4R 2W7, Canada.
Marie-Claire ChevrierHéma-Québec, Transfusion Medicine, Québec City & Montréal, Québec, H4R 2W7, Canada.
Lucie RichardHéma-Québec, Transfusion Medicine, Québec City & Montréal, Québec, H4R 2W7, Canada.
Antoine LewinHéma-Québec, Medical Affairs & Innovation, Québec City & Montréal, Québec, G1V 5G3, Canada.
Patrick TrépanierHéma-Québec, Medical Affairs & Innovation, Québec City & Montréal, Québec, G1V 5G3, Canada.ORCID https://orcid.org/0000-0002-8645-6230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19human leukocyte antigensred blood cell antigensSARS-CoV-2susceptibility

Identifiers

PMID36844192
PMCPMC9941981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.